NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 434 filers reported holding NOVAVAX INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $135,133 | +77.6% | 10,674 | +1.6% | 0.00% | – |
Q3 2023 | $76,078 | -85.2% | 10,508 | -79.0% | 0.00% | -100.0% |
Q4 2022 | $514,062 | -49.2% | 50,006 | -10.0% | 0.00% | -50.0% |
Q3 2022 | $1,012,000 | -56.3% | 55,588 | +23.4% | 0.00% | -60.0% |
Q2 2022 | $2,317,000 | +5.9% | 45,046 | +51.6% | 0.01% | +25.0% |
Q1 2022 | $2,188,000 | -41.6% | 29,711 | +13.5% | 0.00% | -42.9% |
Q4 2021 | $3,745,000 | +0.2% | 26,175 | +45.2% | 0.01% | -12.5% |
Q3 2021 | $3,736,000 | -0.3% | 18,023 | +2.1% | 0.01% | 0.0% |
Q2 2021 | $3,747,000 | -0.9% | 17,650 | -15.3% | 0.01% | -11.1% |
Q1 2021 | $3,780,000 | +52.6% | 20,846 | -6.2% | 0.01% | +50.0% |
Q4 2020 | $2,477,000 | +10.7% | 22,216 | +7.6% | 0.01% | 0.0% |
Q3 2020 | $2,237,000 | +16.4% | 20,643 | -10.5% | 0.01% | 0.0% |
Q2 2020 | $1,921,000 | +961.3% | 23,052 | +72.8% | 0.01% | +500.0% |
Q1 2020 | $181,000 | – | 13,338 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |